Safety profile of treatments administered in COVID 19 infection in pregnant women

SARS-CoV-2 infection has unexpectedly arrived in our society. In pregnant women, the situation has been similar to general population. Some drugs have been used empirically, and obstetricians have to consider whether the same treatments used in the general population were valid for pregnant women wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Sánchez, N., De la Calle Fernández-Miranda, M., Bartha, J.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906532/
https://www.ncbi.nlm.nih.gov/pubmed/33654337
http://dx.doi.org/10.1016/j.gine.2021.01.004
_version_ 1783655308617318400
author Martínez-Sánchez, N.
De la Calle Fernández-Miranda, M.
Bartha, J.L.
author_facet Martínez-Sánchez, N.
De la Calle Fernández-Miranda, M.
Bartha, J.L.
author_sort Martínez-Sánchez, N.
collection PubMed
description SARS-CoV-2 infection has unexpectedly arrived in our society. In pregnant women, the situation has been similar to general population. Some drugs have been used empirically, and obstetricians have to consider whether the same treatments used in the general population were valid for pregnant women with severe disease, according to their safety profile for both the mother and the fetus. There has been a wide experience with the use of hydroxychloroquine and lopinavir/ritonavir in pregnant women. Tocilizumab and interferon beta could be used if benefits exceed risks. There is no experience using remdesivir in pregnancy.
format Online
Article
Text
id pubmed-7906532
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-79065322021-02-26 Safety profile of treatments administered in COVID 19 infection in pregnant women Martínez-Sánchez, N. De la Calle Fernández-Miranda, M. Bartha, J.L. Clin Invest Ginecol Obstet Review Article SARS-CoV-2 infection has unexpectedly arrived in our society. In pregnant women, the situation has been similar to general population. Some drugs have been used empirically, and obstetricians have to consider whether the same treatments used in the general population were valid for pregnant women with severe disease, according to their safety profile for both the mother and the fetus. There has been a wide experience with the use of hydroxychloroquine and lopinavir/ritonavir in pregnant women. Tocilizumab and interferon beta could be used if benefits exceed risks. There is no experience using remdesivir in pregnancy. Published by Elsevier España, S.L.U. 2021 2021-02-25 /pmc/articles/PMC7906532/ /pubmed/33654337 http://dx.doi.org/10.1016/j.gine.2021.01.004 Text en © 2021 Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Martínez-Sánchez, N.
De la Calle Fernández-Miranda, M.
Bartha, J.L.
Safety profile of treatments administered in COVID 19 infection in pregnant women
title Safety profile of treatments administered in COVID 19 infection in pregnant women
title_full Safety profile of treatments administered in COVID 19 infection in pregnant women
title_fullStr Safety profile of treatments administered in COVID 19 infection in pregnant women
title_full_unstemmed Safety profile of treatments administered in COVID 19 infection in pregnant women
title_short Safety profile of treatments administered in COVID 19 infection in pregnant women
title_sort safety profile of treatments administered in covid 19 infection in pregnant women
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906532/
https://www.ncbi.nlm.nih.gov/pubmed/33654337
http://dx.doi.org/10.1016/j.gine.2021.01.004
work_keys_str_mv AT martinezsanchezn safetyprofileoftreatmentsadministeredincovid19infectioninpregnantwomen
AT delacallefernandezmirandam safetyprofileoftreatmentsadministeredincovid19infectioninpregnantwomen
AT barthajl safetyprofileoftreatmentsadministeredincovid19infectioninpregnantwomen

Ejemplares similares